Quebec’s RNA Hub
Promises to showcase all stakeholders in the RNA therapy sector at the provincial, national, and international levels.
Subscribe to the newsletter
Win a ticket to BIO International 2027
Life sciences and health technologies
Overview of Quebec’s RNA Therapy Sector
Training the next generation of Quebec talent
Factory School: RNA-specific training
Innovation
Services
Training
Expertise
About Us
Established through the collaborative efforts of CQDM, Axelys and Montréal InVivo, AReNA aims to unite and champion Quebec’s leading players in the RNA therapy sector.
Quebec’s RNA industry
RNA Therapies News
Employment : CQDM is Looking for an Innovation Advisor for AReNA
Pitch Contest for RNA Startups
Callout to Quebec enterprises for a delegation to RNA Leaders USA in September 2026
Médicament Québec announces $1.3 million in funding for the DePTAQ Network
What RNA therapies teach us about our ecosystem’s maturity
Researchers at the Université de Sherbrooke use RNA to correct genetic defects linked to rare neurological diseases
Major financial support awarded by Genome Quebec L’Institut de recherche clinique de Montreal
Axelys presents Quebec’s RNA ecosystem to investors at an event in Montreal
The RNA Revolution Accelerates: Pharmaceutical and Biotechnology Giants Invest Billions in Next-Generation Therapies
Overview of Quebec’s RNA Therapy Sector
Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
The Future of RNA Therapies: Amid Uncertainty, Quebec Emerges as a Hub for RNA Innovation.
CASTL Launches Pilot Edition of mRNA/mRNA-LNP Biomanufacturing Training – October 1–3, 2025 | Montreal
The IRCM’s Martin Sauvageau talks to Radio-Canada : End of American Funding for mRNA Vaccines
Citeline podcast episode looks at the state of RNA therapeutics with Novotech’s Tom Hickey
Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
Interest for RNA Therapy Deals Keeps Growing Among Big Pharmaceuticals
Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)
AReNA shines at BIO 2025
Eli Lilly and Company to Acquire Verve Therapeutics for Up to $1.3 Billion
AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention
Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector
DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader
MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.
D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress
AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal
Panagiotis Prinos appointed as Director of Réseau DePTAQ
The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.
CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM
Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke
Two panelists represent AReNA at Leyton Connect’s 5-to-7
AReNA attended FISQ
AReNA attends CASTL’s Open Door Day
Epitopea closes their $31 million pre-Series A financing.
Congratulations to the Nobel Prize winners in Medicine!
Congratulations to the 23 recipients of the D2R funding programs
The creation of training programs to meet the needs of the RNA therapeutics industry
The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies
A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec
Quebec Launches AReNA to Become a Global Leader in RNA Therapies
A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec
The long-overlooked molecule that will define a generation of science
Our trusted partners supporting our expertise
